Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.03 USD | -0.44% | -0.99% | +21.01% |
Financials (USD)
Sales 2024 * | 4.49B | Sales 2025 * | 4.69B | Capitalization | 8.91B |
---|---|---|---|---|---|
Net income 2024 * | -32M | Net income 2025 * | 65M | EV / Sales 2024 * | 3.05 x |
Net Debt 2024 * | 4.77B | Net Debt 2025 * | 4.28B | EV / Sales 2025 * | 2.81 x |
P/E ratio 2024 * |
-373
x | P/E ratio 2025 * |
71.6
x | Employees | 9,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.34% |
Latest transcript on Elanco Animal Health Incorporated
1 day | -0.44% | ||
1 week | -0.99% | ||
Current month | +1.98% | ||
1 month | +5.81% | ||
3 months | +14.69% | ||
6 months | +31.03% | ||
Current year | +21.01% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Simmons
CEO | Chief Executive Officer | 56 | 18-06-30 |
Todd Young
DFI | Director of Finance/CFO | 52 | 18-12-13 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Doyle
BRD | Director/Board Member | 61 | 20-12-13 |
Art Garcia
BRD | Director/Board Member | 63 | 19-05-07 |
John Bilbrey
BRD | Director/Board Member | 67 | 19-03-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.88% | 208 M€ | +13.63% | - | |
10.49% | 1 M€ | -.--% | ||
0.35% | 21 M€ | +8.79% | - | |
0.33% | 2 M€ | +9.20% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 18.03 | -0.44% | 2,257,753 |
24-06-13 | 18.11 | +1.29% | 2,516,037 |
24-06-12 | 17.88 | -2.56% | 3,942,083 |
24-06-11 | 18.35 | +0.60% | 5,761,432 |
24-06-10 | 18.24 | +0.16% | 2,644,614 |
Delayed Quote Nyse, June 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.01% | 8.91B | |
+21.62% | 3.6B | |
-5.56% | 3.04B | |
+13.68% | 1.67B | |
-5.27% | 1.23B | |
-29.81% | 1.16B | |
-31.11% | 1.15B | |
-22.47% | 1.01B | |
-12.32% | 916M | |
-3.22% | 889M |
- Stock Market
- Equities
- ELAN Stock